Is based in Miami, FL, FAMRI as a result as a result a class action lawsuit in October 1991 against the tobacco industry. FAMRI is a not-for – profit organization whose mission is to to sponsor scientific and medical research for the early detection, prevention, treatment and cure of diseases and medical conditions of the exposure to tobacco smoke. For further information, please visit.
‘Since FAMRI creation, it has more than 130 scholarships totaling over $ 60 million to some of the best scientists provided in the most prestigious institutions in the world of foundation mission further We welcome Weizmann and the scientists , the center in the FAMRI family. ‘.. The new center will cancer lung cancer research with a focus on the cases of the disease caused by second-hand tobacco smoke and mainstream as well as patient care issues. It is important He added:ut that associate lung cancer Weizmann to world-class cancer and biomedical researchers with leading oncologists from the Sheba Medical Center, a major research – oriented Israeli hospital for its pioneering approaches to cancer diagnosis and treatment is known.The severity of the disorder and potential for human – to-human spreading have a significant incentive for accelerating the development a human vaccine for avian flu.. Highly pathogenic avian influenza A viral, for human – H5N1 has emerged in the last ten years and brought death and disease at national and wild bird populations. December 2006, 261 laboratory-confirmed human cases of H5N1 that World Health Organization was have been reported what. The deaths of more than one half of infected During human cases keep relatively rare and are large extent have the result of the direct transfer of the virus from infected birds registered several cases of human-to-human transmission.
The first human trial of a DNA vaccine designed in order to prevent H5N1 infectious began to on the 21st. December 2006, if the vaccine can was managed to the first voluntary at the National Institutes of Health Clinical Center in Bethesda, MD. Against the virus. Vaccine Research Center at the National Institutes of Allergy and Infectious Diseases , any one of NIH institutes develop the vaccine. Vaccine contains no infectious material from influenza virus.
The vaccine contains no infectious material, and the virus in every phase of in every phase the manufacturing process, remarked Julie E. Lead investigator of the trial. ‘It is impossible the vaccine causing an infection, she says, United States government employed of new technologies known to to safely stimulates broad immune response.